Diminished adenosine a1 receptor expression in pancreatic a-cells may contribute to the patholog y of type 1 diabetes

Diabetes

Volumn 62, Issue 12, 2013, Pages 4208-4219

  Yip, Linda ^a   Taylor, Cariel ^a   Whiting, Chan C ^a   Fathman, C Garrison ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR;

ADOLESCENT; ADOPTIVE TRANSFER; ADULT; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLUCAGONEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET ALPHA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON-SECRETING CELLS; HUMANS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MIDDLE AGED; PREDIABETIC STATE; RECEPTOR, ADENOSINE A1; SPLEEN;

EID: 84891758721     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0614     Document Type: Article

References (50)

1. Ohneda A, Kobayashi T, Nihei J, Tochino Y, Kanaya H, Makino S. Insulin and glucagon in spontaneously diabetic non-obese mice. Diabetologia 1984;27:460-463
2. Ohneda A, Kobayashi T, Nihei J, Nishikawa K. Glucagon in spontaneously diabetic KK mice. Horm Metab Res 1981;13:207-211
3. Ohneda A, Kobayashi T, Nihei J, Tochino Y, Kanaya H, Makino S. Secretion of glucagon in spontaneously diabetic NOD mice. J Jap Diabet Soc 1981;24: 202
4. Greenbaum CJ, Prigeon RL, D'Alessio DA. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes 2002;51:951-957
5. Unger RH, Aguilar-Parada E, Müller WA, Eisentraut AM. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 1970;49:837-848
6. Dinneen S, Alzaid A, Turk D, Rizza R. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 1995; 38:337-343
7. Walker JN, Ramracheya R, Zhang Q, Johnson PR, Braun M, Rorsman P. Regulation of glucagon secretion by glucose: paracrine, intrinsic or both? Diabetes Obes Metab 2011;13(Suppl. 1):95-105
8. Pelegri C, Rosmalen JG, Durant S, et al. Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background. Mol Med 2001;7:311-319
9. Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y. Lymphocytic insulitis in a 'non-obese diabetic (NOD)' strain of mice: an immunohistochemical and electron microscope investivation. Biomed Res 1982;3: 429-443
10. Huang YC, Rupnik MS, Karimian N, et al. In situ electrophysiological examination of pancreatic a cells in the streptozotocin-induced diabetes model, revealing the cellular basis of glucagon hypersecretion. Diabetes 2013;62:519-530
11. Cheng JT, Chi TC, Liu IM. Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats. Auton Neurosci 2000;83:127-133
12. Johansson SM, Salehi A, Sandström ME, et al. A1 receptor deficiency causes increased insulin and glucagon secretion in mice. Biochem Pharmacol 2007;74:1628-1635
13. Yang GK, Fredholm BB, Kieffer TJ, Kwok YN. Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice. Am J Physiol Endocrinol Metab 2012;303:E180-E190
14. Salehi A, Parandeh F, Fredholm BB, Grapengiesser E, Hellman B. Absence of adenosine A1 receptors unmasks pulses of insulin release and prolongs those of glucagon and somatostatin. Life Sci 2009;85:470-476
15. Yip L, Su L, Sheng D, et al. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 2009;10:1026-1033
16. Shizuru JA, Gregory AK, Chao CT, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987;237:278-280
17. Marselli L, Thorne J, Ahn YB, et al. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008;93:1046-1053
18. Burnstock G, Novak I. Purinergic signalling in the pancreas in health and disease. J Endocrinol 2012;213:123-141
19. Németh ZH, Bleich D, Csóka B, et al. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J 2007;21:2379-2388
20. Dhalla AK, Chisholm JW, Reaven GM, Belardinelli L. A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 2009:271-295
21. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 1999;55:614-624
22. Novak I. Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signal 2008;4:237-253
23. Wise H. The roles played by highly truncated splice variants of G proteincoupled receptors. J Mol Signal 2012;7:13
24. Sumi Y, Woehrle T, Chen Y, Yao Y, Li A, Junger WG. Adrenergic receptor activation involves ATP release and feedback through purinergic receptors. Am J Physiol Cell Physiol 2010;299:C1118-C1126
25. Rorsman P, Braun M, Zhang Q. Regulation of calcium in pancreatic a-and b-cells in health and disease. Cell Calcium 2012;51:300-308
26. Li DP, Chen SR, Pan HL. Adenosine inhibits paraventricular pre-sympathetic neurons through ATP-dependent potassium channels. J Neurochem 2010; 113:530-542
27. Ambrósio AF, Malva JO, Carvalho AP, Carvalho CM. Inhibition of N-,P/Qand other types of Ca2+ channels in rat hippocampal nerve terminals by the adenosine A1 receptor. Eur J Pharmacol 1997;340:301-310
28. Yang GK, Squires PE, Tian F, Kieffer TJ, Kwok YN, Dale N. Glucose decreases extracellular adenosine levels in isolated mouse and rat pancreatic islets. Islets 2012;4:4
29. Tudurí E, Filiputti E, Carneiro EM, Quesada I. Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors. Am J Physiol Endocrinol Metab 2008;294: E952-E960
30. Chapal J, Loubatières-Mariani MM, Petit P, Roye M. Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol 1985;86:565-569
31. Daly JW, Padgett WL. Agonist activity of 2-and 59-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1-and A2-adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 1992;43:1089-1093
32. St Hilaire C, Carroll SH, Chen H, Ravid K. Mechanisms of induction of adenosine receptor genes and its functional significance. J Cell Physiol 2009;218:35-44
33. Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012;8:e1002552
34. Ortis F, Naamane N, Flamez D, et al. Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells. Diabetes 2010;59:358-374
35. Ren H, Stiles GL. Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. J Biol Chem 1994;269:3104-3110
36. Ren H, Stiles GL. Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression. Proc Natl Acad Sci USA 1994;91:4864-4866
37. Pechhold K, Zhu X, Harrison VS, et al. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes. Diabetes 2009;58:1175-1184
38. Gómez Dumm CL, Cónsole GM, Luna GC, Dardenne M, Goya RG. Quantitative immunohistochemical changes in the endocrine pancreas of nonobese diabetic (NOD) mice. Pancreas 1995;11:396-401
39. Leiter EH, Coleman DL, Eppig JJ. Endocrine pancreatic cells of postnatal diabetes (db) mice in cell culture. In Vitro 1979;15:507-521
40. Coulaud J, Durant S, Homo-Delarche F. Glucose homeostasis in prediabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation. Rev Diabet Stud 2010;7:36-46
41. Amrani A, Durant S, Throsby M, Coulaud J, Dardenne M, Homo-Delarche F. Glucose homeostasis in the nonobese diabetic mouse at the prediabetic stage. Endocrinology 1998;139:1115-1124
42. Hollander PH, Asplin CM, Kniaz D, Hansen JA, Palmer JP. Beta-cell dysfunction in nondiabetic HLA identical siblings of insulin-dependent diabetics. Diabetes 1982;31:149-153
43. Palmer JP, Helqvist S, Spinas GA, et al. Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989;38:1211-1216
44. Aaen K, Rygaard J, Josefsen K, et al. Dependence of antigen expression on functional state of beta-cells. Diabetes 1990;39:697-701
45. Buschard K, Brogren CH, Röpke C, Rygaard J. Antigen expression of the pancreatic beta-cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2. APMIS 1988;96:342-346
46. Buschard K. The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Autoimmunity 1991;10:65-69
47. Ziegler AG, Bachmann W, Rabl W. Prophylactic insulin treatment in relatives at high risk for type 1 diabetes. Diabetes Metab Rev 1993;9:289-293
48. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011; 60:391-397
49. Brand CL, Jørgensen PN, Svendsen I, Holst JJ. Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits. Diabetes 1996;45:1076-1083
50. Johnson DG, Goebel CU, Hruby VJ, Bregman MD, Trivedi D. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 1982;215:1115-1116